[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

EA200601189A1 - Фармацевтическая оральная дозированная форма, включающая в себя нестероидное противовоспалительное лекарственное средство (нпвс) и обладающая хорошими вкусовыми качествами - Google Patents

Фармацевтическая оральная дозированная форма, включающая в себя нестероидное противовоспалительное лекарственное средство (нпвс) и обладающая хорошими вкусовыми качествами

Info

Publication number
EA200601189A1
EA200601189A1 EA200601189A EA200601189A EA200601189A1 EA 200601189 A1 EA200601189 A1 EA 200601189A1 EA 200601189 A EA200601189 A EA 200601189A EA 200601189 A EA200601189 A EA 200601189A EA 200601189 A1 EA200601189 A1 EA 200601189A1
Authority
EA
Eurasian Patent Office
Prior art keywords
nonsteridoid
nsaid
good taste
pharmaceutical oral
taste qualities
Prior art date
Application number
EA200601189A
Other languages
English (en)
Other versions
EA009515B1 (ru
Inventor
Леонардо Маркитто
Франческа Марьетти
Лорелла Раньи
Original Assignee
Ацьенде Кимике Рьюните Анджелини Франческо A.K.P.A.Ф. С.П.А.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ацьенде Кимике Рьюните Анджелини Франческо A.K.P.A.Ф. С.П.А. filed Critical Ацьенде Кимике Рьюните Анджелини Франческо A.K.P.A.Ф. С.П.А.
Publication of EA200601189A1 publication Critical patent/EA200601189A1/ru
Publication of EA009515B1 publication Critical patent/EA009515B1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pain & Pain Management (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Rheumatology (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Оральная фармацевтическая дозированная форма, включающая в себя трометамин и НПВС, выбранный из группы, состоящей из ибупрофена, напроксена и флурбипрофена, отличающаяся тем, что она включает также соединение, выбранное из группы, включающей в себя глицин, витамин В6 и их смеси.
EA200601189A 2003-12-19 2004-12-16 Фармацевтическая оральная дозированная форма, включающая в себя нестероидное противовоспалительное лекарственное средство EA009515B1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT002523A ITMI20032523A1 (it) 2003-12-19 2003-12-19 Forma di dosaggio per uso orale comprendente un farmaco
PCT/EP2004/014465 WO2005058276A1 (en) 2003-12-19 2004-12-16 Pharmaceutical oral dosage form comprising a non-steroidal anti-inflammatory drug, and having goog palatability

Publications (2)

Publication Number Publication Date
EA200601189A1 true EA200601189A1 (ru) 2006-10-27
EA009515B1 EA009515B1 (ru) 2008-02-28

Family

ID=34685625

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200601189A EA009515B1 (ru) 2003-12-19 2004-12-16 Фармацевтическая оральная дозированная форма, включающая в себя нестероидное противовоспалительное лекарственное средство

Country Status (20)

Country Link
US (1) US9968552B2 (ru)
EP (1) EP1694295B1 (ru)
JP (1) JP4958558B2 (ru)
KR (1) KR101122174B1 (ru)
CN (1) CN100486643C (ru)
AR (1) AR048137A1 (ru)
AU (1) AU2004298763B2 (ru)
BR (1) BRPI0417809B1 (ru)
CA (1) CA2547194C (ru)
DK (1) DK1694295T3 (ru)
EA (1) EA009515B1 (ru)
ES (1) ES2388139T3 (ru)
IL (1) IL175827A0 (ru)
IT (1) ITMI20032523A1 (ru)
MX (1) MXPA06007052A (ru)
PL (1) PL1694295T3 (ru)
PT (1) PT1694295E (ru)
SI (1) SI1694295T1 (ru)
UA (1) UA83531C2 (ru)
WO (1) WO2005058276A1 (ru)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1397132B1 (it) 2009-12-01 2013-01-04 Alfa Wassermann Spa Composizioni comprendenti antiinfiammatori non steroidei.
DK3236938T3 (da) * 2014-12-25 2019-07-01 Sanovel Ilac Sanayi Ve Ticaret As Orale topikale vandige farmaceutiske sammensætninger af flurbiprofen og dexpanthenol
US20180228832A1 (en) * 2015-08-18 2018-08-16 Pharma Seeds Create, Llc Stomatological composition containing nsaid or heparin compound
EP3406239B1 (en) * 2017-05-22 2021-10-20 Epifarma Srl Palatable ketoprofen lysine salt solutions
US20210260003A9 (en) 2017-11-30 2021-08-26 Aziende Chimiche Riunite Angelini Francesco A.C.R.A.F. S.P.A. Stable liquid composition of ketoprofen, salts and enantiomers thereof
PL4021418T3 (pl) * 2019-08-26 2025-02-10 Dsm Ip Assets B.V. Stała doustna postać dawkowania zawierająca naproksen i witaminę b1
CN114129512B (zh) * 2021-12-14 2023-12-22 艾迈华创(武汉)科技有限公司 一种可口服用萘普生溶液制剂及其制备方法与应用
KR20230090186A (ko) 2021-12-14 2023-06-21 메디케어제약 주식회사 파라세타몰 및 나프록센을 포함하는 약제학적 복합제제

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU4028772A (en) * 1971-04-02 1973-09-27 Merck & Co., Inc Chemical processes
HU185926B (en) 1979-09-27 1985-04-28 Agostne Kahan Process for preparing water soluble derivatives of non-steroid antiinflammatory compositions and pharmaceutical compositins containing such derivatives
JPH0768120B2 (ja) * 1987-03-09 1995-07-26 日清製粉株式会社 非ステロイド性抗炎症薬経口投与用組成物
US5296236A (en) * 1988-09-16 1994-03-22 Recordati S.A., Chemical And Pharmaceutical Company Controlled release therapeutic system for a liquid pharmaceutical formulations
US5183829A (en) 1991-09-27 1993-02-02 Applied Analytical Industries, Inc. Oral liquid compositions of non-steroidal anti-inflammatory drugs
ZA945944B (en) * 1993-08-13 1996-02-08 Eurand America Inc Procedure for encapsulating nsaids
US5626838A (en) * 1995-03-13 1997-05-06 The Procter & Gamble Company Use of ketorolac for treatment of squamous cell carcinomas of the oral cavity or oropharynx
AU7637296A (en) * 1995-11-14 1997-06-05 Farmarc Nederland Bv Complex of naproxen and beta-cyclodextrin
GB9601398D0 (en) * 1996-01-24 1996-03-27 Piper Edwina M Composition
JPH11139970A (ja) * 1997-11-06 1999-05-25 Doujin Iyaku Kako Kk 経口液剤
US6426090B1 (en) * 1999-04-06 2002-07-30 Wm. Wrigley Jr. Company Over-coated product including tableted center and medicament
AR035642A1 (es) 2000-05-26 2004-06-23 Pharmacia Corp Uso de una composicion de celecoxib para el alivio rapido del dolor
US20030039687A1 (en) * 2001-08-01 2003-02-27 Michael Corbo Taste masking composition
ITMI20020986A1 (it) * 2002-05-10 2003-11-10 Acraf Composizione a base di diclofenac per il trattamento topico di affezioni del cavo orofaringeo
EP1974751A1 (en) 2007-03-26 2008-10-01 The Jordanian Pharmaceutical Manufacturing Co. Formulations for non-steroidal anti-inflammatory drugs

Also Published As

Publication number Publication date
WO2005058276A1 (en) 2005-06-30
CA2547194A1 (en) 2005-06-30
AU2004298763B2 (en) 2009-12-03
BRPI0417809A (pt) 2007-04-10
KR20060120206A (ko) 2006-11-24
PL1694295T3 (pl) 2012-11-30
JP2007514701A (ja) 2007-06-07
CN1893922A (zh) 2007-01-10
JP4958558B2 (ja) 2012-06-20
IL175827A0 (en) 2006-10-05
HK1091404A1 (en) 2007-01-19
CA2547194C (en) 2011-12-13
KR101122174B1 (ko) 2012-03-15
DK1694295T3 (da) 2012-09-24
MXPA06007052A (es) 2007-01-30
US9968552B2 (en) 2018-05-15
ITMI20032523A1 (it) 2005-06-20
US20080292606A1 (en) 2008-11-27
EP1694295B1 (en) 2012-06-20
EA009515B1 (ru) 2008-02-28
EP1694295A1 (en) 2006-08-30
CN100486643C (zh) 2009-05-13
ES2388139T3 (es) 2012-10-09
AR048137A1 (es) 2006-04-05
AU2004298763A1 (en) 2005-06-30
UA83531C2 (ru) 2008-07-25
SI1694295T1 (sl) 2012-10-30
BRPI0417809B1 (pt) 2018-09-25
PT1694295E (pt) 2012-07-23

Similar Documents

Publication Publication Date Title
EA201100958A1 (ru) Фармацевтическая пероральная дозированная лекарственная форма на основе ингибиторов dpp iv
HUP0003705A2 (hu) Antiepilektikumokat tartalmazó fájdalomcsillapító készítmények és ilyen készítményeket alkalmazó eljárások
ATE502629T1 (de) Pharmazeutische kombination mit 3- (3- dimethylamino-1-ethyl-2-methyl-propyl) phenol und einem nsar
NO20043998L (no) Oral administreringsform for tungtloselige basiske aktive virkestoffer
UA108594C2 (ru) Единичная дозированная фармацевтическая форма
HRP20060147B1 (hr) Terapijski sustav s kontroliranim otpuštanjem za nazalnu primjenu
CY1112738T1 (el) Μια συνδυασμενη συνθεση που περιεχει ιβουπροφαινη και παρακεταμολη
BG66093B1 (bg) Състави с контролирано освобождаване, съдържащи нимесулид
DE50005529D1 (de) Orale darreichungsformen zur verabreichung einer fixen kombination von tramadol und diclofenac
EA200701923A1 (ru) Лекарственная форма для перорального введения витамина
NO20062605L (no) Farmasoytisk formulering inneholdende smakssubstanser med forbedrede farmasoytiske egenskaper
EA200601189A1 (ru) Фармацевтическая оральная дозированная форма, включающая в себя нестероидное противовоспалительное лекарственное средство (нпвс) и обладающая хорошими вкусовыми качествами
DE60210139D1 (de) Pharmazeutische zusammensetzungen enthaltend tegaserod
ATE499939T1 (de) Neue pharmazeutische zusammenstezungen, flibanserin polymorph a enthaltend
ATE363840T1 (de) Capsaicinoid enthaltende pharmazeutische zusammensetzung zur oralen verabreichung
ATE299697T1 (de) Feste zubereitungen mit ramipril
ATE332690T1 (de) Perindopril enthaltende pharmazeutische zusammensetzung mit oraler dispersion
DE602005021475D1 (de) Magenresistente pharmazeutische dosierform mit n-(2-(2-phthalimidoethoxy)-acetyl)-l-alanyl-d-glutaminsäure (lk-423)
PT1249231E (pt) Formulacoes farmaceuticas contendo substancias activas anti-inflamatorias e sua utilizacao
EA200501565A1 (ru) Предназначенная для перорального приёма лекарственная форма для антагонистов протонного насоса
NO20040857L (no) Ny oral forlenget frigivelses doseringsform.
EA200601015A1 (ru) Пероральные композиции дезоксипеганина и их применение
DE69907481D1 (de) Entzündungshemmende pharmazeutische formulierungen
ATE357220T1 (de) Pharmazeutische zusammensetzung mit modifizierter freisetzung
FR2839645B1 (fr) Systeme multilamellaire pour l'administration de substances actives (en particulier des medicaments) par ingestion par la voie orale

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ BY KZ KG MD TJ TM

MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): RU